3 min read FDA Approves New Treatments: Oral Semaglutide & Lupus Nephritis Drug The FDA has recently approved new treatments for two significant health challenges: cardiovascular risk reduction in type 2 diabetes and lupus nephritis
Focus on incorporating: Lean proteins (chicken, fish, eggs, legumes) to support muscle mass and provide sustained energy Complex carbohydrates (wholegrain bread, brown rice, oats) which release energy gradually and help maintain stable blood glucose levels Healthy fats (avocado, nuts, olive oil) in moderate amounts for essential fatty acids and fat-soluble vitamin absorption Colourful vegetables and fruits to ensure adequate vitamin and mineral intake, particularly iron, B vitamins, and vitamin C Given the reduced appetite, eating smaller, frequent meals throughout the day may be better tolerated than three large meals
The prevalence of comorbidities was as follows: 51.1% of patients with hypertension, 50% with diabetes mellitus, 5.2% with psychoactive substance use, and 0.5% experiencing problems related to housing and economic circumstances
Rare but serious side effects that require urgent medical attention include acute pancreatitis (severe, persistent abdominal pain, sometimes with vomiting) and gallbladder disease (right upper quadrant pain, fever, jaundice)
Compounded tirzepatide is prepared by licensed 503A pharmacies and shipped directly to you, serving all 50 states with no insurance requirement or membership fees
